检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Acalabrutinib +/- obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naive chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.

Jeff Porter Sharman,Miklos Egyed,Wojciech Jurczak,Alan P. Skarbnik,Manali K. Kamdar,Talha Munir,Laura Fogliatto,Yair Herishanu,Versha Banerji,George Follows,Patricia Walker,Karin Karlsson,Paolo Ghia,Ann Janssens,Emmanuelle Ferrant,Veerendra Munugalavadla,Ting Yu,Min Hui Wang,Jennifer Ann Woyach

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 12|浏览10
暂无评分
关键词
chronic lymphocytic leukemia,obinutuzumab,chlorambucil,five-year
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要